ArticleScientific reports2025
Day 6 vitrified blastocyst transfer on day 5 vs. day 6 of progesterone shows similar outcomes in HRT-FET cycles: a cohort study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Studies have suggested transferring Day 6 (D6) vitrified blastocyst in a frozen embryo transfer (FET) cycle. This study investigates whether D6 blastocysts should be transferred on the 5th or 6th day of progesterone administration during a hormonal replacement therapy (HRT) FET cycle. A cohort of 746 vitrified D6 single blastocyst HRT-FET cycles was examined in a public Fertility Clinic. Of these, 576 blastocysts were transferred on the 6th day of progesterone (2013-2021), and 170 on the 5th day (2021-2022). The primary outcome was live birth rate (LBR), secondary outcomes were biochemical pregnancy rate (PR), clinical pregnancy rate (CPR), and early pregnancy loss rate (EPLR). No significant differences in LBR, PR, CPR and EPLR were observed, between transfer on the 5th vs. the 6th day of progesterone (23.5% vs. 25.7%, p = 0.76, 38.8% vs. 41.2%, p = 0.61, 26.0% vs. 29.5%, p = 0.40 and 33.3% vs. 28.3%, p = 0.45, respectively). There was no significant difference in basic characteristics and top-quality blastocyst transfers. The timing of D6 vitrified blastocyst transferred on the 5th or the 6th day of progesterone administration in HRT-FET cycles did not significantly impact reproductive outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.